Oxford BioMedica has indicated it could consider a private equity takeover under the right circumstances, even after rejecting multiple unsolicited approaches from Sweden’s EQT earlier this year, according to a report by the Financial Times citing comments from its chief executive. To a report by private equity wire. 05.06.2026




















